For those who appreciate value investing, NASDAQ:SUPN is a compelling option with its solid fundamentals.

Last update: Aug 6, 2024

Uncover the hidden value in SUPERNUS PHARMACEUTICALS INC (NASDAQ:SUPN) as our stock screening tool recommends it as an undervalued choice. NASDAQ:SUPN maintains a robust financial position and offers an attractive pricing perspective. Let's dig deeper into the analysis.

Understanding NASDAQ:SUPN's Valuation

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NASDAQ:SUPN, the assigned 8 reflects its valuation:

Based on the Price/Earnings ratio, SUPN is valued cheaper than 83.42% of the companies in the same industry.
SUPN is valuated rather cheaply when we compare the Price/Earnings ratio to 28.44, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio, SUPN is valued cheaper than 84.46% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 19.90. SUPN is valued slightly cheaper when compared to this.
SUPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SUPN is cheaper than 85.49% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SUPN is valued cheaper than 87.56% of the companies in the same industry.
SUPN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SUPN may justify a higher PE ratio.
A more expensive valuation may be justified as SUPN's earnings are expected to grow with 27.03% in the coming years.

Evaluating Profitability: NASDAQ:SUPN

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:SUPN, the assigned 6 is noteworthy for profitability:

With an excellent Return On Assets value of -1.19%, SUPN belongs to the best of the industry, outperforming 80.31% of the companies in the same industry.
The Return On Equity of SUPN (-1.67%) is better than 81.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.52%, SUPN is in the better half of the industry, outperforming 76.68% of the companies in the same industry.
SUPN's Operating Margin of 1.09% is fine compared to the rest of the industry. SUPN outperforms 77.20% of its industry peers.
The Gross Margin of SUPN (87.17%) is better than 89.64% of its industry peers.

A Closer Look at Health for NASDAQ:SUPN

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:SUPN has received a 6 out of 10:

SUPN has an Altman-Z score of 3.74. This indicates that SUPN is financially healthy and has little risk of bankruptcy at the moment.
SUPN's Altman-Z score of 3.74 is fine compared to the rest of the industry. SUPN outperforms 75.65% of its industry peers.
SUPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

Growth Examination for NASDAQ:SUPN

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:SUPN was assigned a score of 5 for growth:

The Earnings Per Share has grown by an impressive 53.93% over the past year.
The Revenue has been growing by 8.24% on average over the past years. This is quite good.
The Earnings Per Share is expected to grow by 28.45% on average over the next years. This is a very strong growth
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

More Decent Value stocks can be found in our Decent Value screener.

For an up to date full fundamental analysis you can check the fundamental report of SUPN

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.